| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.09 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.22 | 0.09 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |